NYMOX PHARMACEUTICAL CORPORATION Interest Expense
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Interest Expense of $63.00 thousand for the 3-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Expense Statement
ifrs-full:InterestExpense · last filed 2025-01-02
- NYMOX PHARMACEUTICAL CORPORATION interest expense for the quarter ending 2024-09-30 was $63.00K, a 186.36% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION interest expense for the quarter ending 2023-09-30 was $22.00K, a 120.00% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION interest expense for the quarter ending 2023-06-30 was $10.00K, a 900.00% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION interest expense for the quarter ending 2022-09-30 was $10.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $63.00K 6-K · filed 2025-01-02 | $140.00K 6-K · filed 2025-01-02 | |
| 2023-09-30 | $22.00K 6-K · filed 2025-01-02 | $32.00K derived: sum of 2 quarters · filed 2025-01-02 | $33.00K 6-K · filed 2025-01-02 |
| 2023-06-30 | $10.00K 6-K · filed 2023-08-14 | $11.00K 6-K · filed 2023-08-14 | |
| 2022-09-30 | $10.00K 6-K · filed 2023-11-15 | $11.00K derived: sum of 2 quarters · filed 2023-11-15 | $16.00K 6-K · filed 2023-11-15 |
| 2022-06-30 | $1.00K 6-K · filed 2023-08-14 | $6.00K 6-K · filed 2023-08-14 |